We can't find the internet
Attempting to reconnectSomething went wrong!
Attempting to reconnectSouth Korean solar stocks jumped as U.S. restrictions on Chinese solar products came into focus ahead of the Trump-Xi summit.
The San Diego company’s flexible dosing results could carve out real market share in the obesity drug race.
IBBQ offers concentrated biotech exposure with lower costs and stronger recent returns, while IYH provides broader sector diversification and higher dividend income.
YETI stock looks attractive after a 20% pullback, with raised FY26 guidance, strong DTC/international growth and low P/E—see the 25% upside thesis.
The auto-parts retailer is winning market share as it expands globally.
Pfizer delivered a Q2 double beat, raised full-year revenue guidance, and benefits from pipeline progress. Read why PFE stock is a Buy.
Oil prices were mixed Wednesday, amid hopes of a diplomatic solution to the conflict in the Middle East after Iran and the U.S. had talks.
Frontline's Q2 adjusted profit hit a record $580M, with most Q3 capacity already secured at elevated rates. Read what supports a Buy rating for FRO stock.
GM's unveiling more hunky V8 engines amid a boom in hybrid demand seems like a mistake, but here are some things for investors to consider.
Today reads warmer than 21 of the last 28 scored days. Click a bar to read that day's stories.